Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000299879 | SCV000445468 | benign | BAP1-related tumor predisposition syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000422693 | SCV000521676 | benign | not specified | 2016-04-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000299879 | SCV000563726 | benign | BAP1-related tumor predisposition syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566867 | SCV000664589 | benign | Hereditary cancer-predisposing syndrome | 2015-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000566867 | SCV000682574 | benign | Hereditary cancer-predisposing syndrome | 2016-03-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003656111 | SCV001157040 | benign | not provided | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000422693 | SCV002046984 | benign | not specified | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000422693 | SCV002550754 | benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316494 | SCV004016325 | benign | Melanoma, uveal, susceptibility to, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003656111 | SCV005306446 | benign | not provided | criteria provided, single submitter | not provided | ||
Myriad Genetics, |
RCV000299879 | SCV005404612 | benign | BAP1-related tumor predisposition syndrome | 2024-07-16 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
KCCC/NGS Laboratory, |
RCV000299879 | SCV005881107 | benign | BAP1-related tumor predisposition syndrome | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000422693 | SCV001807339 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000422693 | SCV001958115 | benign | not specified | no assertion criteria provided | clinical testing |